Palisades Revival Tests New U.S. Nuclear Playbook at Entergy’s Former Plant
- Holtec bought the Palisades plant from Entergy in June 2022 and is pursuing its operational restart.
- Palisades is a test for Entergy and the sector on returning formerly utility-owned reactors to service.
- Entergy’s sale to Holtec will influence policy and commercial choices about retirements, restarts, and private ownership.
Palisades Revival Tests New U.S. Nuclear Playbook
Holtec International is advancing a restart of the Palisades nuclear plant it bought from Entergy in June 2022, a project that industry watchers view as a bellwether for U.S. reactor restarts. The company is pursuing an operational comeback under its Holtec Palisades subsidiary and is working through regulatory and technical milestones that the Nuclear Regulatory Commission and Department of Energy have adapted to encourage. The DOE has committed a $1.5 billion loan package to support Palisades, disbursing tranches through 2025, signalling federal backing for private-led restarts of idled reactors.
Regulators and Holtec are navigating novel pathways to relicense and restore systems, but material equipment problems — notably with steam generators — push the target restart from the original end-of-2025 timetable into mid-2026. The case is shaping a template for reviving other U.S. reactors: it combines federal financing, NRC flexibility on relicensing, and a private operator willing to assume long-term ownership and operation rather than reselling the asset. That approach contrasts with past decommissioning-first outcomes and highlights a shift toward preserving existing zero-carbon capacity where feasible.
For Entergy and the broader nuclear sector, Palisades is a test of whether merchant and formerly utility-owned reactors can be returned to service under new commercial and regulatory arrangements. Entergy’s sale of the plant to Holtec in 2022 set the stage for this experiment; the outcome will influence policy and commercial decisions about retirements, restarts and the role of private firms in sustaining aging nuclear infrastructure. The Palisades timeline, technical hurdles and funding model are being watched closely by plant owners, state regulators and policymakers seeking to balance reliability, emissions goals and safety.
Holtec files confidential IPO paperwork
Separately, Holtec confidentially files for an initial public offering with the SEC, having earlier signalled a potential 2026 debut as investor interest in nuclear infrastructure rises. Media estimates have suggested Holtec could be valued in the multi‑billion dollar range, reflecting its expanding role across restarts, small modular reactors, used fuel management and thermal equipment.
Decommissioning portfolio and Indian Point dispute
Holtec’s decommissioning arm, Holtec Decommissioning International, runs Oyster Creek and Pilgrim and is engaged at Indian Point — a site New York’s governor opposes restarting in favour of new upstate builds. Oyster Creek and Pilgrim are well past points of no return in decommissioning, underscoring Holtec’s dual role in both taking plants out of service and attempting to bring others back online.
